News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,772 Results
Type
Article (14908)
Company Profile (299)
Press Release (266559)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79839)
Career Advice (162)
Deals (13337)
Drug Delivery (39)
Drug Development (50707)
Employer Resources (31)
FDA (5838)
Job Trends (5168)
News (145087)
Policy (10071)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (920)
Accelerated approval (19)
Adcomms (14)
Allergies (84)
Alliances (21761)
ALS (126)
Alzheimer's disease (1034)
Antibody-drug conjugate (ADC) (243)
Approvals (6032)
Artificial intelligence (264)
Autoimmune disease (117)
Automation (9)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (46)
Breast cancer (345)
Cancer (3149)
Cardiovascular disease (239)
Career advice (147)
Career pathing (7)
CAR-T (222)
CDC (5)
Cell therapy (573)
Cervical cancer (14)
Clinical research (43709)
Collaboration (1161)
Company closure (2)
Compensation (600)
Complete response letters (41)
COVID-19 (1101)
CRISPR (86)
C-suite (559)
Cystic fibrosis (112)
Data (4347)
Denatured (15)
Depression (93)
Diabetes (256)
Diagnostics (1382)
Digital health (12)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (195)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (217)
Earnings (31659)
Editorial (26)
Employer branding (4)
Employer resources (29)
Events (51693)
Executive appointments (627)
FDA (7601)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (991)
Gene editing (183)
Generative AI (22)
Gene therapy (495)
GLP-1 (507)
Government (1148)
Grass and pollen (3)
Guidances (166)
Healthcare (6611)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (193)
Immuno-oncology (42)
Indications (70)
Infectious disease (1208)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (40)
Intellectual property (167)
Interviews (18)
IPO (7346)
IRA (12)
Job creations (867)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1400)
Liver cancer (41)
Longevity (11)
Lung cancer (423)
Lymphoma (250)
Machine learning (24)
Management (7)
Manufacturing (379)
MASH (131)
Medical device (2664)
Medtech (2673)
Mergers & acquisitions (6622)
Metabolic disorders (731)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (233)
Neuropsychiatric disorders (70)
Neuroscience (1961)
Neurotech (1)
NextGen: Class of 2026 (2034)
Non-profit (866)
Now hiring (31)
Obesity (332)
Opinion (125)
Ovarian cancer (132)
Pain (102)
Pancreatic cancer (163)
Parkinson's disease (232)
Partnered (12)
Patents (302)
Patient recruitment (339)
Peanut (44)
People (26677)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15488)
Phase 2 (20311)
Phase 3 (12827)
Pipeline (3324)
Policy (90)
Postmarket research (853)
Preclinical (6539)
Press Release (30)
Prostate cancer (146)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (659)
Real estate (1448)
Recruiting (12)
Regulatory (9914)
Reports (19)
Research institute (972)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (184)
Series B (140)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2006)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (338)
Venture capital (69)
Weight loss (174)
Women's health (26)
Worklife (2)
Date
Today (58)
Last 7 days (329)
Last 30 days (1133)
Last 365 days (17857)
2026 (1859)
2025 (18098)
2024 (20543)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14350)
2014 (10393)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (154)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18266)
Australia (3113)
California (7115)
Canada (1847)
China (780)
Colorado (248)
Connecticut (252)
Delaware (236)
Europe (39198)
Florida (909)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (395)
India (36)
Indiana (161)
Iowa (8)
Japan (227)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (738)
Massachusetts (5615)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1652)
New Mexico (13)
New York (1772)
North Carolina (835)
North Dakota (6)
Northern California (3502)
Ohio (179)
Oklahoma (11)
Oregon (24)
Pennsylvania (1284)
Puerto Rico (9)
Rhode Island (25)
South America (215)
South Carolina (9)
Southern California (2819)
Tennessee (40)
Texas (916)
United States (23460)
Utah (97)
Virginia (137)
Washington D.C. (37)
Washington State (593)
West Virginia (1)
Wisconsin (46)
281,772 Results for "inhibikase therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
November 21, 2025
·
4 min read
Press Releases
Inhibikase Therapeutics Announces Third Quarter 2025 Financial Results and Highlights Recent Activity
November 17, 2025
·
9 min read
Press Releases
Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension
November 21, 2025
·
5 min read
Press Releases
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
November 21, 2025
·
4 min read
Press Releases
Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
August 20, 2025
·
3 min read
Press Releases
Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
August 15, 2025
·
10 min read
Neurodegenerative disease
Inhibikase Scraps Parkinson’s Drug After Disappointing Mid-Stage Data
Inhibikase’s setback continues biopharma’s losing streak against Parkinson’s, marked by several clinical failures and abandoned assets in recent months.
January 30, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
April 14, 2025
·
3 min read
Press Releases
Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity
May 15, 2025
·
6 min read
Press Releases
Inhibikase Therapeutics Announces 2024 Financial Results and Highlights Recent Activity
March 28, 2025
·
7 min read
1 of 28,178
Next
